Profile | GDS5420 / 231837_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 330.99 | 60 |
GSM1296119 | B_lesional_pre-dose | 405.71 | 64 |
GSM1296076 | C_lesional_pre-dose | 275.89 | 59 |
GSM1296092 | D_lesional_pre-dose | 488.25 | 68 |
GSM1296103 | E_lesional_pre-dose | 564.04 | 70 |
GSM1296078 | F_lesional_pre-dose | 398.41 | 65 |
GSM1296107 | G_lesional_pre-dose | 306.75 | 59 |
GSM1296109 | H_lesional_pre-dose | 278.46 | 57 |
GSM1296080 | I_lesional_pre-dose | 336.47 | 61 |
GSM1296090 | J_lesional_pre-dose | 503.73 | 68 |
GSM1296074 | K_lesional_pre-dose | 290.84 | 60 |
GSM1296111 | L_lesional_pre-dose | 403.19 | 64 |
GSM1296099 | M_lesional_pre-dose | 375.71 | 62 |
GSM1296086 | O_lesional_pre-dose | 362.02 | 63 |
GSM1296117 | P_lesional_pre-dose | 362.15 | 62 |
GSM1296113 | Q_lesional_pre-dose | 440.23 | 65 |
GSM1296096 | R_lesional_pre-dose | 445.77 | 66 |
GSM1296105 | S_lesional_pre-dose | 340.69 | 61 |
GSM1296098 | T_lesional_pre-dose | 446.46 | 66 |
GSM1296101 | U_lesional_pre-dose | 316 | 59 |
GSM1296121 | V_lesional_pre-dose | 330.15 | 60 |
GSM1296088 | W_lesional_pre-dose | 381.43 | 63 |
GSM1296082 | X_lesional_pre-dose | 435.41 | 66 |
GSM1296115 | Y_lesional_pre-dose | 325.47 | 60 |
GSM1296084 | Z_lesional_pre-dose | 493.59 | 67 |
GSM1296072 | B_lesional_day8 | 500.85 | 68 |
GSM1296069 | L_lesional_day8 | 431.01 | 65 |
GSM1296071 | P_lesional_day8 | 274.19 | 56 |
GSM1296070 | Y_lesional_day8 | 308.36 | 59 |
GSM1296073 | V_lesional_day8 | 410.86 | 65 |
GSM1296034 | A_lesional_day15 | 350.32 | 61 |
GSM1296041 | G_lesional_day15 | 329.37 | 61 |
GSM1296035 | R_lesional_day15 | 415.49 | 64 |
GSM1296038 | U_lesional_day15 | 304.66 | 59 |
GSM1296047 | B_lesional_day15 | 498.32 | 67 |
GSM1296039 | E_lesional_day15 | 489.49 | 68 |
GSM1296042 | H_lesional_day15 | 330.24 | 60 |
GSM1296043 | L_lesional_day15 | 313.22 | 59 |
GSM1296037 | M_lesional_day15 | 241.16 | 55 |
GSM1296046 | P_lesional_day15 | 249.84 | 55 |
GSM1296044 | Q_lesional_day15 | 288.67 | 57 |
GSM1296045 | Y_lesional_day15 | 284.11 | 57 |
GSM1296025 | C_lesional_day15 | 112.07 | 44 |
GSM1296033 | D_lesional_day15 | 362.42 | 62 |
GSM1296027 | I_lesional_day15 | 457.05 | 67 |
GSM1296032 | J_lesional_day15 | 342.23 | 61 |
GSM1296024 | K_lesional_day15 | 180.89 | 51 |
GSM1296031 | W_lesional_day15 | 361.49 | 62 |
GSM1296028 | X_lesional_day15 | 359.14 | 62 |
GSM1296029 | Z_lesional_day15 | 416.42 | 64 |
GSM1296026 | F_lesional_day15 | 171.65 | 51 |
GSM1296030 | O_lesional_day15 | 343.91 | 62 |
GSM1296040 | S_lesional_day15 | 279.35 | 58 |
GSM1296036 | T_lesional_day15 | 502.19 | 67 |
GSM1296048 | V_lesional_day15 | 414.89 | 65 |
GSM1296059 | A_lesional_day43 | 463.29 | 66 |
GSM1296066 | G_lesional_day43 | 291.06 | 58 |
GSM1296060 | R_lesional_day43 | 510.09 | 68 |
GSM1296063 | U_lesional_day43 | 293.56 | 59 |
GSM1296064 | E_lesional_day43 | 327.23 | 61 |
GSM1296067 | H_lesional_day43 | 307.29 | 58 |
GSM1296062 | M_lesional_day43 | 423.12 | 64 |
GSM1296068 | Q_lesional_day43 | 288.26 | 57 |
GSM1296050 | C_lesional_day43 | 242.17 | 56 |
GSM1296057 | D_lesional_day43 | 505.23 | 68 |
GSM1296052 | I_lesional_day43 | 373.78 | 63 |
GSM1296054 | J_lesional_day43 | 451.69 | 65 |
GSM1296049 | K_lesional_day43 | 369.67 | 63 |
GSM1296055 | W_lesional_day43 | 295.04 | 58 |
GSM1296053 | X_lesional_day43 | 288.24 | 58 |
GSM1296058 | Z_lesional_day43 | 495.93 | 67 |
GSM1296051 | F_lesional_day43 | 356.11 | 63 |
GSM1296056 | O_lesional_day43 | 333.93 | 62 |
GSM1296065 | S_lesional_day43 | 394.47 | 63 |
GSM1296061 | T_lesional_day43 | 323.1 | 60 |
GSM1296095 | A_non-lesional_pre-dose | 410.57 | 65 |
GSM1296120 | B_non-lesional_pre-dose | 351.11 | 61 |
GSM1296077 | C_non-lesional_pre-dose | 112.94 | 44 |
GSM1296093 | D_non-lesional_pre-dose | 349.84 | 61 |
GSM1296104 | E_non-lesional_pre-dose | 331.95 | 61 |
GSM1296079 | F_non-lesional_pre-dose | 196.36 | 53 |
GSM1296108 | G_non-lesional_pre-dose | 244.71 | 55 |
GSM1296110 | H_non-lesional_pre-dose | 287.99 | 57 |
GSM1296081 | I_non-lesional_pre-dose | 134.71 | 47 |
GSM1296091 | J_non-lesional_pre-dose | 315.06 | 60 |
GSM1296075 | K_non-lesional_pre-dose | 200.99 | 54 |
GSM1296112 | L_non-lesional_pre-dose | 285.27 | 57 |
GSM1296100 | M_non-lesional_pre-dose | 201.34 | 52 |
GSM1296087 | O_non-lesional_pre-dose | 323.91 | 61 |
GSM1296118 | P_non-lesional_pre-dose | 192.1 | 50 |
GSM1296114 | Q_non-lesional_pre-dose | 372.2 | 62 |
GSM1296097 | R_non-lesional_pre-dose | 350.16 | 62 |
GSM1296106 | S_non-lesional_pre-dose | 323.32 | 59 |
GSM1296102 | U_non-lesional_pre-dose | 263.53 | 56 |
GSM1296122 | V_non-lesional_pre-dose | 284.43 | 58 |
GSM1296089 | W_non-lesional_pre-dose | 316.8 | 59 |
GSM1296083 | X_non-lesional_pre-dose | 305.36 | 59 |
GSM1296116 | Y_non-lesional_pre-dose | 341.9 | 60 |
GSM1296085 | Z_non-lesional_pre-dose | 339.16 | 61 |